The CEO Interviewhere is the piece I keep coming back to, extracted from the PRC interview post deal. Stripping back any doubt, there is something real here in my opinion...18 cents sounds a little shy of forward earnings:
Let’s talk numbers. Can you elaborate on the actual figures?
HV: Do you see this smile on my face? I can assure everyone that AbbVie is rewarding Sirona Biochem appropriately for our breakthrough technology. Although I am contractually bound to not comment on how much we are receiving, suffice it to say that it will be substantial given that we are getting royalty payments on the global sales of AbbVie’s products based on our patents.
AbbVie has an agreement that allows them to commercialize and market TFC-1067 worldwide into their established global network.